Coverage
-
April 09, 2015
Valeant Pharmaceuticals International Inc. and William Ackman's Pershing Square Capital Management LP hedge fund agreed Thursday to bury the hatchet with Allergan Inc. after the sides lobbed damages claims at one other tied to Valeant and Pershing's failed bid to buy the Botox maker in a $55 billion hostile takeover.
16 other articles on this case.
View all »